Effects of L-arginine on endothelial and cardiac function in rats with heart failure

被引:21
作者
Feng, QP
Fortin, AJ
Lu, XR
Malcolm, J
Arnold, O
机构
[1] Univ Western Ontario, London Hlth Sci Ctr Res Inc, Cardiol Res Lab, Dept Med, London, ON, Canada
[2] Univ Western Ontario, London Hlth Sci Ctr Res Inc, Cardiol Res Lab, Dept Pharmacol & Toxicol, London, ON, Canada
关键词
heart failure; L-arginine; nitric oxide (NO); endothelial function; cardiovascular function;
D O I
10.1016/S0014-2999(99)00360-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We examined the effects of chronic oral L-arginine treatment on endothelial and cardiovascular function in rats with heart failure induced by coronary artery ligation. Both heart failure and sham-operated rats were treated with either L-arginine in drinking water (12.5 or 50 g/l) or water placebo for 8 weeks following surgery. Plasma L-arginine levels in heart failure rats (153 +/- 11 mu M) were lower than sham rats (201 +/- 13 mu M, P < 0.05). The lower dose L-arginine treatment improved endothelium-dependent relaxation of isolated aortic rings of heart failure rats, while the higher dose of L-arginine treatment did not. Neither low nor high dose of L-arginine treatment improved hemodynamic parameters in heart failure rats. Thus, chronic oral L-arginine treatment at a dose of 12.5 g/l in drinking water improves endothelium-dependent relaxation, but fails to improve in vivo cardiac function in rats with heart failure. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 35 条
[11]   BLUNTED RENAL RESPONSE TO ATRIAL-NATRIURETIC-PEPTIDE IN CONGESTIVE-HEART-FAILURE RATS IS REVERSED BY THE ALPHA-2-ADRENERGIC AGONIST CLONIDINE [J].
FENG, QP ;
HEDNER, T ;
HEDNER, J ;
PETTERSSON, A .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 (05) :776-782
[12]  
FENG QP, 1996, CAN J CARDIOL, V12, pE125
[13]   NITRIC-OXIDE SYNTHASE ISOZYMES - CHARACTERIZATION, PURIFICATION, MOLECULAR-CLONING, AND FUNCTIONS [J].
FORSTERMANN, U ;
CLOSS, EI ;
POLLOCK, JS ;
NAKANE, M ;
SCHWARZ, P ;
GATH, I ;
KLEINERT, H .
HYPERTENSION, 1994, 23 (06) :1121-1131
[14]   Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure -: Their relation to lesion site and β-adrenergic receptor therapy [J].
Fukuchi, M ;
Hussain, SNA ;
Giaid, A .
CIRCULATION, 1998, 98 (02) :132-139
[15]  
Grisham Matthew B., 1995, Methods (Orlando), V7, P84, DOI 10.1006/meth.1995.1012
[16]   Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy [J].
Habib, FM ;
Springall, DR ;
Davies, GJ ;
Oakley, CM ;
Yacoub, MH ;
Polak, JM .
LANCET, 1996, 347 (9009) :1151-1155
[17]   Expression of inducible nitric oxide synthase fin human heart failure [J].
Haywood, GA ;
Tsao, PS ;
vonderLeyen, HE ;
Mann, MJ ;
Kelling, PJ ;
Trindade, PT ;
Lewis, NP ;
Byrne, CD ;
Rickenbacher, PR ;
Bishopric, NH ;
Cooke, JP ;
McKenna, WJ ;
Fowler, MB .
CIRCULATION, 1996, 93 (06) :1087-1094
[18]  
HIRAI T, 1995, CARDIOVASC RES, V30, P469, DOI 10.1016/S0008-6363(95)00068-2
[19]   EFFECTS OF L-ARGININE ON IMPAIRED ACETYLCHOLINE-INDUCED AND ISCHEMIC VASODILATION OF THE FOREARM IN PATIENTS WITH HEART-FAILURE [J].
HIROOKA, Y ;
IMAIZUMI, T ;
TAGAWA, T ;
SHIRAMOTO, M ;
ENDO, T ;
ANDO, S ;
TAKESHITA, A .
CIRCULATION, 1994, 90 (02) :658-668
[20]   ENDOTHELIUM-DEPENDENT VASODILATION IS ATTENUATED IN PATIENTS WITH HEART-FAILURE [J].
KUBO, SH ;
RECTOR, TS ;
BANK, AJ ;
WILLIAMS, RE ;
HEIFETZ, SM .
CIRCULATION, 1991, 84 (04) :1589-1596